The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Mnjoyan, Zakar H ^a   Doan, Dennis ^a   Brandon, Jimi Lynn ^b   Felix, Kumar ^a   Sitter, Christy L ^c   Rege, Ajay A ^c   Brock, Tommy A ^c   Fujise, Ken ^a,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

5 Bromo 2 deoxyuridine; Carotid artery injury; Harlan rats; Sasco rats; Terminal deoxynucleotidyl transferase deoxyuridine nick end labeling; Vascular smooth muscle cells

Indexed keywords

BROXURIDINE; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTERY RESISTANCE; ARTICLE; CAROTID ARTERY INJURY; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BALLOON DILATATION; CELL CULTURE; CELL MOTION; CELL SHAPE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; DISEASE MODEL; HYPERPLASIA; METABOLISM; NICK END LABELING; PATHOLOGY; SPRAGUE DAWLEY RAT; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME;

ANIMALS; APOPTOSIS; BALLOON DILATATION; BROMODEOXYURIDINE; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; HYPERPLASIA; IN SITU NICK-END LABELING; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; THYMIDINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 44949098276     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91527.2007     Document Type: Article

References (34)

1. Alves da Costa C, Paitel E, Mattson MP, Amson R, Telerman A, Ancolio K, Checler F. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc Natl Acad Sci USA 99: 4043-4048, 2002.
2. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Dallas, TX: American Heart Association, 2004.
3. Assadnia S, Rapp JP, Nestor AL, Pringle T, Cerilli GJ, Gunning WT 3rd, Webb TH, Kligman M, Allison DC. Strain differences in neointimal hyperplasia in the rat. Circ Res 84: 1252-1257, 1999.
4. Bilder G, Wentz T, Leadley R, Amin D, Byan L, O'Conner B, Needle S, Galczenski H, Bostwick J, Kasiewski C, Myers M, Spada A, Merkel L, Ly C, Persons P, Page K, Perrone M, Dunwiddie C. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation 99: 3292-3299, 1999.
5. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49: 327-333, 1983.
6. Fuller DD, Baker TL, Behan M, Mitchell GS. Expression of hypoglossal long-term facilitation differs between substrains of Sprague-Dawley rat. Physiol Genomics 4: 175-181, 2001.
7. Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 97: 581-588, 1998.
8. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 156: 1741-1748, 2000.
9. Horibe H, Yamada Y, Ichihara S, Watarai M, Yanase M, Takemoto K, Shimizu S, Izawa H, Takatsu F, Yokota M. Genetic risk for restenosis after coronary balloon angioplasty. Atherosclerosis 174: 181-187, 2004.
10. Horvath C, Welt FG, Nedelman M, Rao P, Rogers C. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 90: 488-494, 2002.
11. Inoue S, Nakazawa T, Cho A, Davastan F, Shilling D, Daum G, Reidy M. Regulation of arterial lesions in mice depends on differential smooth muscle cell migration: a role for sphingosine-1-phosphate receptors. J Vasc Surg 46: 756-763, 2007.
12. Karsch KR, Haase KK, Wehrmann M, Hassenstein S, Hanke H. Smooth muscle cell proliferation and restenosis after stand alone coronary excimer laser angioplasty. J Am Coll Cardiol 17: 991-994, 1991.
13. Kastrati A, Schomig A, Seyfarth M, Koch W, Elezi S, Bottiger C, Mehilli J, Schomig K, von Beckerath N. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99: 1005-1010, 1999.
14. Klinger MM, MacCarter GD, Boozer CN. Body weight and composition in the Sprague Dawley rat: comparison of three outbred sources. Lab Anim Sci 46: 67-70, 1996.
15. Knight E, Bryant S, Keenan C, Kimball J, Barrett D. Two year evaluation of clinical parameters and pathology in Sprague-Dawley rats from different suppliers. Toxicologist 14: 303-314, 1994.
16. + channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res 80: 877-884, 1997.
17. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76: 412-417, 1995.
18. Monraats PS, Pires NM, Agema WR, Zwinderman AH, Schepers A, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, Quax PH, van Vlijmen BJ, Atsma DE, van der Laarse A, van der Wall EE, Jukema JW. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions. Circulation 112: 2417-2425, 2005.
19. Morimoto S, Mizuno Y, Hiramitsu S, Yamada K, Kubo N, Nomura M, Yamaguchi T, Kitazume H, Kodama K, Kurogane H, Shimizu Y, Mizuno K, Chino M, Wantanabe S, Ueda T, Toyoda M, Sekiguchi M. Restenosis after percutaneous transluminal coronary angioplasty - a histopathological study using autopsied hearts. Jpn Circ J 54: 43-56, 1990.
20. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315-1323, 2003.
21. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344: 395-402, 2001.
22. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 17: 433-439, 1991.
23. O'Brien ER, Urieli-Shoval S, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Benditt EP, Schwartz SM. Replication in restenotic atherectomy tissue. Atherosclerosis 152: 117-126, 2000.
24. Oguri M, Kato K, Hibino T, Yokoi K, Segawa T, Matsuo H, Watanabe S, Nozawa Y, Murohara T, Yamada Y. Genetic risk for restenosis after coronary stenting. Atherosclerosis 194: e172-e178, 2007.
25. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T. A potent genetic risk factor for restenosis. Nat Genet 5: 324-325, 1993.
26. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98: 2277-2283, 1996.
27. Sirois MG, Simons M, Edelman ER. Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation 95: 669-676, 1997.
28. Sluka KA, Westlund KN. Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat. Brain Res 579: 67-73, 1992.
29. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103, 1994.
30. Thome LM, Gimple LW, Bachhuber BG, McNamara CA, Ragosta M, Gertz SD, Powers ER, Owens GK, Humphries JE, Sarembock IJ. Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone: potential implications for dosing of antithrombin agents. Circulation 98: 2301-2306, 1998.
31. Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation 107: 98-105, 2003.
32. Turnbull AV, Rivier CL. Sprague-Dawley rats obtained from different vendors exhibit distinct adrenocorticotropin responses to inflammatory stimuli. Neuroendocrinology 70: 186-195, 1999.
33. West WL, Yeomans DC, Proudfit HK. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res 626: 127-135, 1993.
34. Zipes DP, Libby P, Bonow RO, Braunwald E. (editors). Braunwald's Heart Disease. Philadelphia, PA: Elsevier Saunders, 2005, p. 2400.